US$ 23.36
semaglutide cause heart problems GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies SELECT Trial
Description
On January 14 th , Monte Nido Vice President of Adolescent Medicine Rebecka Peebles, MD, FAAP, CEDS, DABOM

Same-day appointments are often available

For the purposes of gathering information and preparing this paper, PubMed, Scopus, Embase, Web of Science, and Google Scholar were searched for peer-reviewed literature in English on 8 and 9 October 2024 and again for updates on 25 January 2025

doi: 10.18632/oncotarget.13189 45
